These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8019790)
21. An immunoradiometric assay for erythrocyte complement (C3b) receptor activity applied to a pediatric population with connective tissue disease. Buffone GJ; Leatherwood CM; Person DA; Brewer EJ Clin Chem; 1983 Oct; 29(10):1720-3. PubMed ID: 6616816 [TBL] [Abstract][Full Text] [Related]
22. Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Scarpa R; Del Puente A; di Girolamo C; della Valle G; Lubrano E; Oriente P Ann Rheum Dis; 1992 Jan; 51(1):78-9. PubMed ID: 1540042 [TBL] [Abstract][Full Text] [Related]
23. Correlative expression of C3b receptors in the glomerulus and on erythrocytes. Minota S; Terai C; Nojima Y; Takano K; Yamada A; Miyakawa Y; Takaku F Clin Immunol Immunopathol; 1986 Jan; 38(1):85-92. PubMed ID: 2934197 [TBL] [Abstract][Full Text] [Related]
24. Over-estimation of the number of complement receptor type 1 (CR1) on erythrocytes. Quadri RA; Schifferli JA Scand J Immunol; 1992 Jul; 36(1):125-30. PubMed ID: 1535450 [TBL] [Abstract][Full Text] [Related]
25. HLA-B27 antigen and rheumatoid arthritis. Jajić Z; Jajić I; Jajić I Acta Med Iugosl; 1991; 45(3):195-202. PubMed ID: 1950638 [TBL] [Abstract][Full Text] [Related]
26. Quantification of complement receptor 1 on erythrocytes: follow-up of HIV-1-infected patients with AIDS-related complex/Walter-Reed 5 under treatment with intravenous immunoglobulin. The ARC-IVIG Study Group. Spycher MO; Späth PJ Vox Sang; 1990; 59 Suppl 1():44-50. PubMed ID: 2146812 [TBL] [Abstract][Full Text] [Related]
27. Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity. Gudmann NS; Siebuhr AS; Christensen AF; Ejstrup L; Sørensen GL; Loft AG; Karsdal MA; Bay-Jensen AC; Munk HL; Junker P Clin Exp Rheumatol; 2017; 35(4):653-659. PubMed ID: 28240584 [TBL] [Abstract][Full Text] [Related]
28. CR1, CD35 in synovial fluid from patients with inflammatory joint diseases. Sadallah S; Lach E; Lutz HU; Schwarz S; Guerne PA; Schifferli JA Arthritis Rheum; 1997 Mar; 40(3):520-6. PubMed ID: 9082940 [TBL] [Abstract][Full Text] [Related]
29. [Diagnostic value of the HLA phenotype in inflammatory rheumatic diseases]. Saraux A; Guedes C; Allain J; Devauchelle V; Valls I; Baron D; Youinou P; Le Goff P Presse Med; 1997 Jun; 26(22):1040-4. PubMed ID: 9246112 [TBL] [Abstract][Full Text] [Related]
30. Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients. Partsch G; Leeb B; Stancikova M; Raffayova H; Eberl G; Hitzelhammer H; Smolen JS Clin Exp Rheumatol; 1996; 14(4):381-6. PubMed ID: 8871836 [TBL] [Abstract][Full Text] [Related]
31. Relationship between human lymphocyte antigen-B27 and clinical features of psoriatic arthritis. Tsai YG; Chang DM; Kuo SY; Wang WM; Chen YC; Lai JH J Microbiol Immunol Infect; 2003 Jun; 36(2):101-4. PubMed ID: 12886960 [TBL] [Abstract][Full Text] [Related]
32. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438 [TBL] [Abstract][Full Text] [Related]
33. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis. Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT; J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834 [TBL] [Abstract][Full Text] [Related]
35. Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies. Raju KR; Sivasankar B; Anand V; Luthra K; Tiwari SC; Dinda AK; Das N; Srivastava LM Asian Pac J Allergy Immunol; 2001 Mar; 19(1):23-7. PubMed ID: 11495296 [TBL] [Abstract][Full Text] [Related]
36. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome. Thomsen BS; Oxholm P; Nielsen H; Manthorpe R Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207 [TBL] [Abstract][Full Text] [Related]
37. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus. Yoshida K; Yukiyama Y; Hirose S; Miyamoto T Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514 [TBL] [Abstract][Full Text] [Related]
38. Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA). Arora M; Kumar A; Das SN; Srivastava LM Clin Exp Immunol; 1998 Jan; 111(1):102-6. PubMed ID: 9472668 [TBL] [Abstract][Full Text] [Related]
39. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease. Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434 [TBL] [Abstract][Full Text] [Related]
40. Activity of type 1 erythrocyte complement receptors in uremia and after renal transplantation. Klinger M; Słowik E; Kopeć W; Szewczyk Z Int J Artif Organs; 1990 Oct; 13(10):658-62. PubMed ID: 2254041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]